JAMA. 2005;293:437-446. The CREATE-ECLA Trial Group Investigators Context: Glucose-insulin-potassium (GIK) infusion is a widely applicable, low-cost therapy that has been postulated to improve mortality in patients wit.....
JAMA. 2005;293:427-435. The CREATE Trial Group Investigators Context: Although reperfusion therapy, aspirin, -blockers, and angiotensin-converting enzyme inhibitors reduce mortality when used early in patients with a.....
Diabetologia. 1999 Nov;42(11):1293-301. Jonsson B, Cook JR, Pedersen TR. Stockholm School of Economics, Stockholm, Sweden.AIMS/HYPOTHESIS: The purpose of this study is to investigate the cost-effectiveness of simvast.....
Circulation. 1992 Aug;86(2):431-8. Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD Investigators......